Urinary protein levels may be an early marker of future cognitive decline in patients with type 2 DM and normal kidney function, according to a new study.
OSA is not simply a marker for poor health but is an independent risk factor for open-angle glaucoma. Both conditions affect millions worldwide.
A healthy 50-year-old woman walks into your office; she is concerned about her risk of breast cancer because right-sided breast cancer was diagnosed in her mother at age 55. She is of Caucasian ancestry and has no other family members with breast, ovarian, or prostate cancer. She has read the news about an actress who had a “cancer gene” and ended up having prophylactic mastectomies. She is very concerned about her risk of developing breast cancer and wants to be “tested.”
The ankle-brachial index is a noninvasive screening tool that can improve cardiovascular event risk stratification.
If drugs could be developed to target tau, they might prevent much of the neurodegeneration that characterizes Alzheimer disease and help prevent or delay dementia.
Elevated levels of the biomarker C-reactive protein in patients with HIV infection increased the risk of MI approximately 2-fold.
A straightforward discussion drove toward attendees toward the more current understanding of the clinical and genetic overlap between the 2 major forms of IBD.
A genetic analysis questions the benefits of raising HDL-C levels to reduce the risk of MI and of the value of HDL-C as a surrogate marker of risk.
With genetic tests rapidly entering medical practice, and some patients even ordering them on their own, the NIH has launched a Genetic Testing Registry to help doctors interpret and follow up on these tests. In this interview, the director of the new Genetic Testing Registry tells why you need it, and what's there for your reference.
A consortium called CPIC has issued a new guideline on genetic tests that can mean the difference between toxic reactions or unrelieved pain for some patients on codeine. Dr. Mary Relling tells why primary care doctors need good information right now about the links between genes and drug response, and where you can find it.